Communicating Risk With Relatives in a Familial Hypercholesterolemia Cascade Screening Program A Summary of the Evidence

被引:11
作者
Allison, Melanie [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA
[2] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA
关键词
cascade screening; familial; hypercholesterolemia; hyperlipidemia; ASSOCIATION EXPERT PANEL; PARTNER NOTIFICATION; RECOMMENDATIONS; GUIDELINES; MANAGEMENT; NEED; HIV;
D O I
10.1097/JCN.0000000000000153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Familial hypercholesterolemia (FH) is the most common inherited, potentially deadly disease, affecting an estimated 600 000 people in the United States. When FH is undiagnosed and untreated, it is linked with early coronary heart disease in more than 50% of men by age 50 years and 30% of women by age 60 years. Cascade screening is the most cost effective method available to identify family members with this disease; however, cascade screening guidelines do not specify best methods to use when contacting relatives. Therefore, I conducted an exhaustive search of the literature to find the most successful communication methods used in contact tracing and cascade screening. Purpose: The purpose of this summary of the evidence was to identify the communication method with greatest impact in having at-risk populations present to a provider for disease screening. These findings will inform clinicians of the most successful methods to implement when cascade screening relatives of known FH patients. Conclusions: Most studies support direct contact of relatives via letter, mailed from the provider. Provider-initiated communication more often resulted in relatives being tested when compared with other methods of communication. Clinical Implications: On the basis of the literature, family members of current FH patients will be more likely to present to a provider for cascade screening if they receive written communication from the provider.
引用
收藏
页码:E1 / E12
页数:12
相关论文
共 28 条
  • [1] Preferences for partner notification method: variation in responses between respondents as index patients and contacts
    Apoola, A.
    Radcliffe, K. W.
    Das, S.
    Robshaw, V.
    Gilleran, G.
    Kumari, B. S.
    Boothby, M.
    Rajakumar, R.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (07) : 493 - 494
  • [2] Aral S, 2004, CLIN INFECT DIS, V38, P104, DOI 10.1086/380131
  • [3] Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia
    Bhatnagar, D
    Morgan, J
    Siddiq, S
    Mackness, MI
    Miller, JP
    Durrington, PN
    [J]. BRITISH MEDICAL JOURNAL, 2000, 321 (7275) : 1497 - 1500A
  • [4] Familial Communication of Research Results: A Need to Know?
    Black, Lee
    McClellan, Kelly A.
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 2011, 39 (04) : 605 - 613
  • [5] American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility
    Bruinooge, SS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2397 - 2406
  • [6] ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    Catapano, Alberico L.
    Reiner, Zeljko
    De Backer, Guy
    Graham, Ian
    Taskinen, Marja-Riitta
    Wiklund, Olov
    Agewall, Stefan
    Alegria, Eduardo
    Chapman, M. John
    Durrington, Paul
    Erdine, Serap
    Halcox, Julian
    Hobbs, Richard
    Kjekshus, John
    Filardi, Pasquale Perrone
    Riccardi, Gabriele
    Storey, Robert F.
    Wood, David
    [J]. ATHEROSCLEROSIS, 2011, 217 (01) : 3 - 46
  • [7] Centers for Disease Control and Prevention, 2010, CDC PODC FAM HYP
  • [8] Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
    Daniels, Stephen R.
    Gidding, Samuel. S.
    de Ferranti, Sarah D.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) : S30 - S37
  • [9] Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: A pilot study
    Ersig, Anne L.
    Williams, Janet K.
    Hadley, Donald W.
    Koehly, Laura M.
    [J]. GENETICS IN MEDICINE, 2009, 11 (10) : 728 - 734
  • [10] Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project
    Hadfield, S. G.
    Horara, S.
    Starr, B. J.
    Yazdgerdi, S.
    Bhatnagar, D.
    Cramb, R.
    Egan, S.
    Everdell, R.
    Ferns, G.
    Jones, A.
    Marenah, C. B.
    Marples, J.
    Prinsloo, P.
    Sneyd, A.
    Stewart, M. F.
    Sandle, L.
    Wang, T.
    Watson, M. S.
    Humphries, S. E.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 199 - 205